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Abstract
In 2010, UCLPartners, a partnership of health care providers and universities in North Central London, began a
collaboration with local commissioners that aimed to think about cancer care and diagnosis diff
differently.
erently. Understanding
that a good patient experience can only be delivered by putting patients first and working together along their journey
from symptoms to recovery,, we brought clinical leaders together with patients to think about how to improve outcomes
for patients, outside institutional barriers
barriers.. From the very beginning this new network, an integrated cancer system,
focused on understanding what mattered most to patients and organising how it worked and how it measured success
around this. Co-designed
ed by conversations and with contributions from over 1,000 clinicians and over 200 patients,
London Cancer’s ten things that matter most to patients are embedded throughout the continuing work of this
organisation. In this article our work to develop these ten topics is described alongside how we used this to create a truly
patient centred integrated cancer system for a population of 3.5 million people in London and Essex.
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Introduction
The vision and need for patient centred care in the
National Health Service has been stated consistently, but
with increasingg vigour, over the last 3 years. The Francis1,
Keogh2 and Berwick3 Reports of 2013 all highlight the
challenges posed by a health service that does not respond
to the concerns of patients and their families and carers.
While there are many varied definitions of patient or
person centred care, we will use the National Voi
Voices
simple definition of “organised around the needs of
individuals”4.
Turning patient centred care from rhetoric to reality is one
of the greatest cultural challenges for health and social care
organisations. This article outlines how a London
London-based
integrated cancer system, London Cancer (Figure 1)
1), a
collaboration of patients, hospitals, charities and local
General Practitioners (GPs) working along the patient
pathway, assessed what mattered most to cancer patients

within its region. It describes the co-production of these
priorities, championed by local clinical leaders who rolerole
modeled these values, and how it has used this ‘what
matters most’ framework to develop pathways of care and
pathway measures that reflect that they treat people, not
simply diseases.
In 2010, 67,713 patients responded to England’s National
Cancer Patient Experience survey, which provided insights
into the care experienced by cancer patients across
England who were treated as day cases or inpatients
during the first three months
hs of 2010. Building on a
previous survey undertaken in 2000 involving over 65,000
cancer patients and a smaller survey undertaken in 2004
involving 4,300 patients, the 2010 survey revealed that
London patients were significantly more critical of cancer
services in regards to:
• being told they could bring family with them to their
appointment;
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Figure 1. Map of the London Cancer integrated cancer system in the UK

•
•
•

getting understandable answers to important
questions from ward nurses;
contacting their Clinical Nurse Specialist;
the general organisation of NHS services, especially
those “reaching” into the community and primary
care.5

Many of the areas where London performed poorly related
to fragmentation as patients moved between organisations,
and not having all their questions answered. By engaging
with existing and new patient audiences and local clinical
teams, London Cancer set about defining priorities for local
pathways through an integrated cancer system.
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Background to London’s First Integrated Cancer
System
In 2010, UCLPartners, at the time a fairly small
partnership of health care providers and universities in
North Central London, was asked, in partnership with
local commissioners, to host and develop a cancer services
provider network. This was envisaged to be fundamentally
different from the previous English Cancer Networks’ way
of working, with a primary focus on patients, rather than
organisational performance, using their voice, through codesign and development, to change services for the better
with clinicians and staff. The Cancer Networks worked
through clinically led ‘Network Site Specific Groups’ with
a separate patient advisory group, known locally as the
Cancer Partnership Group, working alongside these
groups. The new integrated cancer system proposed
having patients embedded in co-design and co-production
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throughout its work, and as ongoing partners. Initially the
focus was a population of 1.5 million people in North
Central London but this grew to 3.5 million with the
inclusion of North East London (since April 2013
UCLPartners has expanded to include mid and South
Essex, West Hertfordshire and South Bedfordshire, a
population of over 6 million people).
Officially established in 2012 in partnership with
commissioners of cancer care, London Cancer is now the
integrated cancer system for North Central and North
East London and the west of Essex in England. London
Cancer is embedded within UCLPartners, an Academic
Health Science Network (AHSN). UCLPartners’ overall
purpose is to translate cutting-edge research and
innovation into measureable health and wealth gains for
patients and populations by enabling strategic partnership
working between hospitals, universities, primary and
community care. For cancer patients, this means we aim to
accelerate improvements in all aspects of cancer patients’
care – from novel and quicker diagnostic pathways
through reducing variation in both the quality of routine
care, in access to ‘state of the art’ therapies and innovation,
to streamlining research delivery so that more patients are
offered access to clinical trials.
When six specialist providers and three local hospitals
across North Central London came together in 2010 to
develop the new integrated cancer system, there were
several clinical indicators or proxies routinely in use to
measure cancer outcomes (one year survival, five year
survival, disease-free progression) but these were generally
at a population level and not understood well by patients.
For specific cancers there were no more relevant measures
or parameters for improvement focused on what patients
felt was most important for them. The lack of patientdefined outcomes, particularly around areas of patient
experience, was a major concern to this area of London,
where providers received much of England’s poorest
feedback through the now annual National Cancer Patient
Experience Survey. It was crucial that the new system
develop better insight into how it might influence
improvement in patient experience.

Methods
Inherent to the change in focus on patient outcomes and
experience was the emergence of a new type of clinical
leadership, one driven by values and a desire for
improvement, rather than process measures or
institutional dominance. The conversion of Network Site
Specific Groups, commonly known as Tumour Boards, to
new Pathway Boards, reflecting through their membership
all care settings (e.g. primary care, psychological support,
rehabilitation) and with skilled patient advocates, flowed
from the new direction of the integrated cancer system.
Pathway Boards brought patients, primary care, carers and
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allied health professionals to the table alongside surgeons,
physicians, oncologists and other members of the
multidisciplinary team. 11 Pathway Boards were set up
with this diverse membership, alongside 5 Expert
Reference Groups that provide knowledge and expertise
of specialist staff working in the areas of chemotherapy,
radiotherapy, nursing, psychosocial support and acute
oncology. Many of the Expert Reference Group members
also sit on a pathway board to bring their disciplinespecific expertise to the tumour-specific discussions. Each
Pathway Board or Expert Reference Group includes at
least one patient or carer representative and meetings are
considered not quorate without one.
Building on the work already started in the system to
understand the experience of brain patients6, an initial task
for these new Pathway Boards was to think differently
about: ‘what does great care look like?’ and if we were to
achieve it, ‘how the system could know care was great? –
what would have changed?’ Pathway Boards were
encouraged to think about what outcomes mattered and
how they might be measured, what might need to change
about the areas of activity and responsibility and
membership to develop a whole-pathway perspective, and
what kind of leadership would be necessary to ensure a full
pathway perspective. In November 2010, following
discussions with their membership, Pathway Board and
Expert Reference Group Chairs submitted their collective
responses to the following questions via a tool that asked
them to outline stages of the pathway and articulate what
great care would look like in this stage and how we might
know care was great:
1. Which 3-5 outcome measures would the Pathway
Board aim to measure for the whole pathway?
2. What might need to change about the Pathway Board
remit [areas of activity and responsibility] & members
when considering the whole pathways and its
outcomes?
3. What might need to be different about the leadership
of Pathway Boards when overseeing the whole
pathway?
4. What might Pathway Boards need to do to improve
education, benchmarking and dissemination across
the system (and more widely)?
As may be expected when such an exercise involves such a
large and diverse group, thinking about care through the
eyes of patients was variably received by the various
professional groups.
The team from UCLPartners was supported in the task of
finding out what mattered most to patients by the North
Central London and West Essex Cancer Partnership
Group and the North East London Cancer Partnership
Group, the service user advisory groups to the previous
cancer networks. These groups brought together cancer
patients, carers and healthcare professionals from across
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the sector interested in improving local cancer services and
the patient experience. With over 40 patients and carers
engaged and involved at any time, it also had involvement
of local and national charities, including Macmillan Cancer
Support.
At a meeting in November 2010, the group were asked to
think about ‘what does great care look like?’ and ‘how
would you know?’ The Chair (a patient representative) had
found work that they had previously done for the previous
network looking at what measures patients and other users
might care about for hospitals but others at their meeting
had not yet had a chance to consider the questions. The
group felt that they would like to revisit this for the whole
pathway for patients and carers, and look at it in greater
depth. Using the same tool as the Pathway Boards and
Expert Reference Groups, with the questions detailed
above, they focused on what a set of measures of
achievement and progress, different to those traditional
population and process measures inherited, might look
like. The group provided a report to the Pathway Board
Chairs in January 2011. Staff collated all the responses to
this exercise and identified themes. A system of grouping
the items via a thematic approach was agreed with the
Cancer Partnership Groups, who also reviewed the final
summary.

Results - What Matters Most?
The following summarises what our communities of
professionals, patients and carers felt were the aspects of
the cancer journey that most impacted on their outcome
and experience. These are not in priority order, as this was
not assessed, but are listed in what the Cancer Partnership
Group of patients and carers felt to be the order that
patients experienced care in their journey through our
system. While many of these overlap in detail, we have
presented these as ten distinct areas that matter most to
London Cancer patients, alongside the context in which the
discussions evolved.
1. Early Diagnosis
All involved felt earlier diagnosis of cancer was crucial. In
North Central London and West Essex 22% of patients
are diagnosed with cancer only when they arrive at hospital
for emergency treatment. In North East London, the
figure is higher at 28%.7
Patients and carers emphasised the importance of public
information and guidance on healthy living and ways of
minimising cancer risk and symptoms of common cancers
and cancer screening programmes. They encouraged
further guidance for GPs and suggested more rapid access
to diagnostic services and associated outpatient
consultation. Providing education for GPs, community
care providers, and others such as emergency room staff
was one suggestion as to how to improve early diagnosis
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by raising awareness of suspicious symptoms to medical
professionals. It was also apparent from the feedback
received that raising and sustaining public awareness of
both prevention, including public health interventions and
campaigns for issues such as smoking cessation, and for
cancer screening programmes, was essential. These themes
were entirely consistent across respondees and led to
earlier detection and diagnosis becoming one of the most
significant streams of activity in the London Cancer
integrated system.
2. Choice
Many of the suggestions relating to improving patient
experience focused on patient choice as a key aspect of
patient centred care. Patients should have a choice, and the
ability to make an informed decision, as to what treatment
to receive and where to receive it. Ensuring the equality of
access to services for patients, particularly with regards to
referrals to regional, national and international centres,
where appropriate, is necessary to offer maximum patient
choice and the best clinical outcomes. Some of the
responses overlapped between choice and communication,
detailing the need to better inform and communicate
where and when choices might be made.
Research is a crucial element in the effort to improve
patient care from early diagnosis to choice and
communication. Providing all patients with the
opportunity to take part in clinical trials was an aim for
staff and patients, every patient can make a contribution
and should be given the opportunity to be considered for
innovative diagnoses and treatments. The suitability of
individual patients to participate in clinical trials should be
discussed at multi-disciplinary team meetings, and patients
offered trials even if they are open at different sites across
the system. Enrolment statistics should be reported and
shared regularly to drive improvement, and the barriers to
participation understood and addressed. These objectives
formed a core, essential part of system-wide scorecards for
cancer pathways.
3. Communication
Communication dominated the response from the Cancer
Partnership Group, with focuses on a number of themes
within this – breaking bad news; open discussion and
shared decision-making around treatment options; keeping
GPs informed throughout treatment; clear communication
around treatment outcomes; and choice of when, and
how, to receive information. The importance of bad news
being delivered sensitively was stressed.
High quality, tailored information should be available to
both patients and staff. This is essential to ensuring
patients are able to make informed choices regarding
treatment decisions, and that they feel supported
throughout their cancer pathway. Patients felt they should
decide what level of information is appropriate to them at
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each stage of their pathway, but should be provided with a
summary information pack detailing the contact details of
their key worker, often an advanced practice registered
nurse, when they first receive their diagnosis. London Cancer
has focused on improving communication between
patients and clinicians through a number of projects,
including delivery of communications training with trained
counsellors and clinical psychologists, use of the Holistic
Needs Assessment (detailed below) and working with
partners to improve written information provision.
4. Travel and Parking
Patient representatives and key workers also felt patients
should be provided with information on travel and parking
options, and the associated cost, prior to their
appointment. There are several transport alternatives –
driving; public transport; and patient transport provided
by hospitals – for attending treatment and appointments in
London but all have inherent flaws or problems for
patients. London Cancer has been working with Macmillan
Cancer Support and the other integrated cancer system in
London to plan an assessment of the various options
available to patients and then work with stakeholders,
including Transport for London and the Mayor’s Office,
on how to improve.
5. Ethos – patients treated as individuals
Patients should receive holistic, empathetic, responsive
and individualised support throughout their pathway.
Patients and carers felt that clinicians needed to consider
the implications of treatment options in terms of resultant
quality of life and possible long term effects of treatment,
as well more immediate issues of mortality and
complications. It was felt that patient satisfaction and
experience scores should serve as a measure of success for
cancer services. London Cancer partners responded to this
by committing to work together in a community of
practice on those areas that could have most impact on
improving patients’ experience of services, using patient
satisfaction and experience scores to demonstrate
improvement.
6. Holistic Assessment of Needs
Patients felt they should specifically have access to
complementary therapies and treatments, rehabilitation
services, and if applicable, to palliative care at the earliest
possible opportunity. Patients and clinicians felt there
needed to be a more systematic way to assess the holistic
needs of each individual patient. Funding from Macmillan
Cancer Support provided assistance in the integration and
rapid role out of defined models of assessment and
support for individuals living with, and beyond, cancer.
Specific areas of focus have included provision of care
plans, and the availability of information directly related to
their needs, and web based information.
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7. Support
Support for patients, through formal and informal
mechanisms, was very important. Patients want to always
have the option of being accompanied by partner/friend at
outpatient appointments. Patients felt having a keyworker
or clinical nurse specialist from the first appointment made
a difference to how supported they felt, and suggested
excellent care included information on support groups,
counseling services, benefits entitlement, and returning to
work. To better meet the needs of patients and carers,
London Cancer has facilitated collaboration between partner
hospital trusts and the non-profit and voluntary sector,
who provide high quality information, guidance and
support.
8. Carers
Carers should be welcomed, and supported throughout
the cancer pathway, involved as early as possible in the
patient journey, and factored into treatment decisions.
Carers should be encouraged to be fully involved
throughout the patient pathway. This should be seen as of
benefit to both the patient and their clinical team. Support
for carers and families was considered crucial throughout
the patient journey but particularly around coping with
advanced cancer and related to end of life care, so that
there is less anxiety about supporting the patient at home.
At a system-level, London Cancer has focused on
encouraging the carer perspective in pathway development
through a greater number of carer representatives.
9. Discharge
Patients and carers stressed the importance of a seamless
and holistic care pathway, which starts and end with a
General Practitioner, who should help facilitate patient
discharge following an inpatient stay. GPs should provide
information and advice to patients, and remain a central
point of contact across the entire cancer pathway. Patients
wanted to be given details of the keyworker who would be
their first point of contact while at home recovering
following treatment, and clear advice on what symptoms
might necessitate further action. Appropriate pain relief
needs to be provided at discharge, with the GP sent
information on treatment, outcome, and ongoing
medication and therapy needs.
10. Seamless (Integrated) Care
There was a strong consensus amongst patients and all
clinical pathway directors that cancer care should be
seamless, with patients managed closely during the whole
pathway through a multi-disciplinary team approach.
Creating a system whereby patients can follow an
integrated care pathway between various organisations and
services across the London Cancer locality was the main
priority for patients. This extends, but is not limited to,
creating and sustaining a positive dialogue and relationship
with: primary and community care, diagnostics, specialist
medical and surgical services, chemotherapy services,
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radiotherapy services, pharmacy, psychological support,
Allied Health Professional services including dietetics and
physiotherapy, ‘late effects’ services, and palliative care.
Reducing delays within this system was another important
point raised. Collaborative working and communication
between the acute providers of cancer care was identified
as the first step to ensuring this occurs. The ability for
perceived delays and “gaps” in pathways to lead to anxiety
and increased distress was noted by many. Reducing
variation and bringing providers together across the
healthcare system, and along the cancer pathway, were
organising principles for clinicians joining up within the
London Cancer Pathway Boards to redesign pathways and
guidelines in partnership with patients.

Discussion
Taking the learning from what our patients had told us,
aligned with clinicians’ views, the partners within the
London Cancer system together identified key themes for
initial focused activity that would align with improving the
most important aspects of the cancer care journey for local
people. These key themes have focused on improvements
in early diagnosis, integration of the care pathway, and
improving holistic assessment of needs, all underpinned by
strong partnership and leadership.
Assessing what matters to patients and those caring for
them, ensuring that there is a shared goal that unites the
interests and activities of all involved in care, to achieve
value is fundamental to UCLPartners’ programmatic
approach, as exemplified in London Cancer. In order to
ensure pathways were focused on what mattered most, a
small set of key metrics were identified with the Cancer
Partnership Groups for each London Cancer Pathway Board
to monitor their progress in implementing integrated
cancer care. We have followed Porter’s ethos of:
“Achieving high value for patients must become the
overarching goal of health care delivery, with value defined
as the health outcomes achieved per dollar spent.”8
Value-based metrics were selected only if they were
clinically useful, in line with the current work plan and
improvement effort; were accessible on a recurrent basis
and requiring minimal manual effort; made better use of
existing data for understanding the entire patient pathway;
and aligned with London Cancer’s objectives in improving
survival, patient experience, and access to innovation and
clinical trials.
Pathway metrics are reported at a system level, reflecting
the care for our local population, against measures that are
important to them and will allow visibility of success.
Current pathway metric development is constrained by the
availability of meaningful data but local solutions including
in-house questionnaires and surveys as well as peer
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interviewing have seen a useful focus on attempting to
measure and track these key items. The profile of those
things that matter most has been raised within
organisations across the partnership and underpinned by
local effort. Alongside this Pathway Boards were
encouraged to develop annual objectives that could each
be tangibly related to the ten things, which mattered most
to patients.
Examples of improvement projects in these areas are
summarised below.
Early Diagnosis
London Cancer led an innovative evaluation in collaboration
with emergency departments across all nine acute NHS
hospital trusts and local GP practices in the London Cancer
region, to understand the reasons why patients are
diagnosed with cancer in this way.9 This has led to new
and more responsive measures of emergency presentation
that will help track this trend in real time.
London Cancer is working collaboratively to shorten the
patient pathway to diagnosis. Doctor Ed Seward at Barts
Health NHS Trust (Consultant Gastroenterologist) has
developed a new service at Whipps Cross Hospital that
opens up the referral pathway for patients with lower
gastrointestinal symptoms beyond the strict criteria for
urgent referral of suspected colorectal cancer. GPs and
patients receive a definitive diagnosis more efficiently
through a ‘straight to test’ model whereby a trained
specialist nurse assesses patients by telephone. This
enables most patients to go directly to the appropriate
endoscopic investigation, according to symptoms and age,
rather than attending clinic first. Clear benefits from the
first 125 patients include faster diagnosis, a reduction in
missed appointments (3% versus 7% on average),
unnecessary clinic visits for the trust and cost savings
across the whole pathway, which could be redeployed for
capacity, communication with primary care or educational
activity to aid further earlier diagnosis.10
Integrated and Optimised Care Pathway
Evidence shows that dedicated specialist centres, treating a
high volume of patients, staffed by expert teams and
equipped with the latest technology and research capability
save lives and reduce complications.11 Clinicians across
London Cancer have been working closely with partners to
ensure that we can achieve the best possible outcomes for
every patient requiring a complex procedure for five rarer
groups of cancers. Building on commissioners
recommendations in 2010, clinicians came together to
develop proposals to consolidate some specialist cancer
services into a partnership of world-class specialist centres
in a new connected system of care - including the best
diagnosis, treatment and recovery care at local hospitals,
primary and community care services - to provide
consistently excellent services. Clinicians believe the
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proposals would allow more rapid improvements in care,
ensure every patient has access to the full range of
treatment options and research opportunities and provide
a consistent level of care no matter where a patient lives or
first receives care. Now agreed by NHS England and local
clinical commissioners, the changes, along with
improvements across the whole care pathway, will save
over 200 lives a year and significantly improve the safety
and outcomes of surgery in many others.12
Clinical Trials and Research
Research studies and clinical trials allow patients to access
the latest interventions not yet available as part of standard
care, and help build the evidence base for changes in
clinical practice that will improve outcomes for all patients.
Our aim across London Cancer is for researchers at the
cutting edge of discoveries to work with patients so that
we can change lives, at a faster pace and at scale13. By
working together as a coordinated network and linking up
our clinical practice with leading medical research and
innovation, we have a remarkable opportunity to give
patients improved access to clinical trials. We are working
closely with the newly formed NIHR Clinical Research
Network: North Thames to improve information for staff
and patients and access to a full portfolio of studies for
our population. 14
Improving Holistic Assessment of Needs and Ethos
With generous support from Macmillan Cancer Support,
London Cancer is continuing its work to introduce the
‘recovery package’ for all patients. This package combines
several interventions which, when delivered together, aim
to improve care co-ordination and outcomes for
individuals living with or after a cancer diagnosis. The
recovery package consists of: holistic needs assessment,
treatment summaries, cancer care reviews (conducted by
GPs) and health and wellbeing events. Since the beginning
of the project, nine trusts have introduced holistic needs
assessments, five have implemented treatment summaries
and six host health and wellbeing events. We have agreed a
standardised treatment summary template, which informs
the patient and the GP of the care and treatment received,
for embedding in all pathways. This document includes
possible treatment toxicities and /or late effects;
symptoms that require referral back to a specialist team, an
ongoing management plan, and any required GP actions to
support the patient. 15

in all of our work. To date, 65 patients are actively
involved in our day-to-day work. In addition to
participation in pathway discussions, patients have
provided invaluable feedback and input into improving
information provision and the quality of clinical letters,
designing patient measures for scorecards, creating content
for the London Cancer website, co-designing improvement
initiatives with clinicians and staff, leading and designing
innovative research, and assisting commissioners in
significant service redesign. It is clear from our work,
however, and the continued focus on this over four years,
that significant time is required for a truly patient centred
approach to gain traction and embed sustainably.

Conclusion
Patient centred care that really shifts outcomes not just on
paper but in the perception of the people we serve
requires us to understand what matters most to patients.
We have worked from this base and with this focus to
direct and prioritise improvement efforts that meet the
needs of patients and their clinicians. In this article we
have described an innovative patient-led and co-designed
approach to service delivery, leadership and redesign,
sustained through a new way of measuring for
improvement. Our efforts to do this have been
underpinned by the belief that if you start with the patient
you have the best chance of keeping your work relevant,
and making the biggest difference for your investment.
Institutional alignment and traditional process
measurement can have limited impact for change when
patients actually experience care along entire pathways in
multiple settings, each as individuals. Accepting this and
looking to organise its work according to these principles,
London Cancer’s partnership continues to be focused on
change created by combining patient voice with clinical
leadership, underpinned by data for improvement. We
have outlined the ten things we keep central to our vision
and how this is enabling the partners within London Cancer
to achieve significant redesign of health care that had not
been possible before in this geography. It is the work of
these committed clinicians, health care leaders, charities
and patient partners that continues to make this possible.
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